This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Neogap Therapeutics Ab. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hans Gronlund: Innovator in HPV Immunotherapy
Introduction
Hans Gronlund is a notable inventor based in Lidingö, Sweden. He has made significant contributions to the field of immunotherapy, particularly in the development of methods for expanding HPV immunogen specific T-cells. His work aims to enhance the treatment and prevention of HPV-related cancers.
Latest Patents
Hans Gronlund holds a patent for a method titled "Method for the expansion of HPV immunogen specific T-cells." This invention outlines a process that includes several steps: providing a phagocytosable particle with a core and a tightly associated HPV immunogen, supplying antigen-presenting cells (APCs), and facilitating the activation of T-cells harvested from a subject. The method aims to create an expanded population of therapeutically useful T-cells for cancer treatment, particularly for HPV positive cancers. He has 1 patent to his name.
Career Highlights
Hans is associated with Neogap Therapeutics AB, a company focused on innovative therapeutic solutions. His work at Neogap Therapeutics has positioned him as a key player in the field of cancer immunotherapy.
Collaborations
Hans collaborates with Ola Winqvist, contributing to advancements in immunotherapy research and development.
Conclusion
Hans Gronlund's innovative work in expanding HPV immunogen specific T-cells represents a significant advancement in cancer treatment. His contributions continue to pave the way for new therapeutic strategies against HPV-related cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile